Category: New products
-

Bone Regeneration Experiment Begun on Space Station
An experiment is underway testing a bone repair biomaterial in lab mice under weightless conditions on the International Space Station.
-

Trial Underway for Kidney Disease Microbiome Therapy
A clinical trial enrolled its first participant testing an engineered bacterial collection as a treatment for enteric hyperoxaluria, a kidney disorder with no approved cure.
-

FDA Clears AI Heart Failure Detection System
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure.
-

Trial Begins Testing Digital Therapy for Anxiety with Lung Disease
A clinical trial is underway testing a mobile app designed to help people with a serious lung disorder manage anxiety that often accompanies the disease.
-

Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays.
-

Virtual Pathology Image Company Opens, Raises $15.2M
A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds.
-

Sustained-Released Eye Treatment Company Raises $11.9M
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round.
-

Trial Shows Insulin Capsules Reduce Blood Glucose Levels
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes.
-

DNA Storage Start-Up Gains €5M in Seed Funds
A new company developing DNA as a data storage medium with sustainable processes is raising €5 million ($US 5.22 million) in seed funding.
-

FDA Clears Digital Health Monitoring System
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use.